1Mathon C, Ankli A, Reich E, Bieri S, Christen P (2014) Screening and determination of sibutramine in adulterated herbal slimming supplements by HPTLC-UV densitometry. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 31: 15-20.

2 Vanherweghem JL, Depierreux M, Tielemans C, Abramowicz D, Dratwa M, et al. (1993) Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 341: 387-91.

3Muller D, Weinmann W, Hermanns-Clausen M (2009) Chinese Slimming Capsules Containing Sibutramine Sold Over the Internet. Dtsch Arztebl Int 106: 218-22.

4Tang MHY, Chen SPL, Ng SW, Chan AYW, Mak TWL (2011) Case series on a diversity of illicit weight-reducing agents: from the well-known to the unexpected. Br J Clin Pharmacol 71: 250-3.

5 Dunnick JK and Hailey JR (1996) Phenolphthalein Exposure Causes Multiple Carcinogenic Effects in Experimental Model Systems. Cancer Res 56: 4922-6.

6Dara L, Hewet J, Lim JK (2008) Hydroxycut hepatotoxicity: A case series and review of liver toxicity from herbal weight loss supplements. World J Gastroenterol 14: 6999-7004.

7Clark DW and Harrison-Woolrych M (2004) Sibutramine may be associated with memory impairment. BMJ 329: 1316.

8Bodhankar SL, Thakurdesai P, Singhal S, Gaur V (2007) Anorexic effect of (R)-Sibutramine: comparison with (R)-sibutramine and (S)-Sibutramine. Indian J Physiol Pharmacol 51: 175-8.

9Cheung BMY, Cheung TT, Samaranayake NR (2013) Safety of Antiobesity Drugs. Ther Adv in Drug Safe 4: 171-81.

10 Daglioglu N and Akcan R (2012) Sibutramine detected in Chinese herbal drug. Nobel Med 8: 100-2.

11 Phattanawasin P, Uthai S, Tasamaporn S, Jariya A, Sarunyaporn K (2012) Quantitative Determination of Sibutramine in Adulterated Herbal Slimming Formulations by TLC-Image Analysis Method. Forensic Sci Int 219: 96-100.

12 Chen SP, Tang MH, Ng SW, Poon WT, Chan AY, et al. (2010) Psychosis associated with usage of herbal slimming products adulterated with sibutramine: a case series. Clin Toxicol 48: 832-8.

13 Slovacek L, SlovacKova B, Pavlik V, Slanska I (2009) Sibutramine- its impact on health-related quality of life and depression among adult obese non diabetic patient. Bratisl Lek Listy 110: 496-9.

14Cooper GS, Longnecker MP, Sandler DP, Ness RB (2000) Risk of ovarian cancer in relation to use of phenolphthalein-containing laxatives. Br J Cancer 83: 404-6.

15 Cooper GS, Longnecker MP, Peters RK (2004) Ovarian cancer risk and use of phenolphthalein-containing laxatives. Pharmacoepidemiol Drug Saf 13: 35-9.

16Nasreddine L, Naja F , Chamieh MC, Adra N, Sibai AM, et al. (2012) Trends in overweight and obesity in Lebanon:evidence from two national cross-sectional surveys (1997 and 2009). BMC Public Health 12: 798-809.

17Ruesten AV, Steffen A, Floegel A, van der DL, Masala G et al. (2011) Trend in Obesity Prevalence in European Adult Cohort Populations during Follow-up since 1996 and their Predictions to 2015. PLoS One 6: e27455.

18 Murphy EL, Schlumpf K, Wright DJ, Cable R, Roback J et al. ( 2012) BMI and obesity in US blood donors: a potential public health role for the blood centre. Public Health Nutr 15: 964-71.

19 Verduin P, Agarwal S, Waltman S (2005) Solutions to obesity: perspectives from the food industry. Am J Clin Nutr 82(suppl): 259S-61S.

20Hayun, Maggadani BP, Amalina N (2016) Determination of sibutramine adulterated in herbal Slimming products using tlc densitometric method. Indonesian J Pharm 27: 15-21.

21 Kang JG and Park CY (2012) Anti-Obesity Drugs: A Review about Their Effects and Safety. Diabetes Metab J 36: 13-25.

22 Racette SB, Deusinger SS, Deusinger RH (2003) Obesity: Overview of Prevalence, Etiology, and Treatment. Phys Ther 83: 276-288.

23Vorona RD, Winn MP, Babineau TW, Eng BP, Feldman HR, et al. (2005) Overweight and Obese Patients in a Primary Care Population report less sleep than patients with a normal body mass index. Arch Intern Med 165(1): 25-30.

24Johansson M, Fransson D, Rundlof T, Huynh N, et al. (2014) A general analytical platform and strategy in search for illegal drugs. Journal of Pharmaceutical and Biomedical Analysis 100: 215-229.

25 Khazan M, Hedayati M, Kobarfard F, Askari S, Azizi F (2014) Identification and determination of synthetic pharmaceuticals as adulterants in eight common herbal weight loss supplements. Iranian Red Crescent Medical Journal 16: e15344.

26 Garg M, Hooda M, Solanki J, Saini S, Das S et al. (2011) A Recent Update on Undeclared Chemicals in Herbal Formulations. JPBMS 9.